Cannabis Market Size, Share, Growth, and Industry Analysis, By Type (CBD,THC), By Application (Medicinal,Recreational,Industrial), Regional Insights and Forecast to 2035

Cannabis Market Overview

The global Cannabis Market is forecast to expand from USD 11855.57 million in 2026 to USD 14091.54 million in 2027, and is expected to reach USD 27496.72 million by 2035, growing at a CAGR of 18.86% over the forecast period.

The global Cannabis Market Size is expanding rapidly with more than 200 million people worldwide reported to have consumed cannabis at least once in their lifetime. The Cannabis Market Analysis shows that medical cannabis accounts for more than 55% of global market share, while recreational cannabis contributes around 35% and industrial hemp-based applications cover close to 10%. The Cannabis Market Forecast highlights that more than 40 countries have legalized cannabis either for medical or recreational use, with over 24 states in the United States approving adult use. Globally, about 77 million people consume cannabis annually, making it the most widely used illicit drug that has shifted to legalized status in many countries.

The Cannabis Industry Report indicates that more than 200 unique strains of cannabis are being commercially grown worldwide, with THC-dominant strains holding approximately 65% of product share. Balanced THC/CBD strains make up 20%, and CBD-dominant strains contribute the remaining 15%. In the Cannabis Market Outlook, online sales channels represent 25% of legal sales in developed markets, with dispensaries and specialty stores maintaining the largest distribution share at 60%. Globally, employment linked to the cannabis sector surpasses 500,000 jobs, while tax collections from cannabis sales exceed USD 20 billion annually in legalized regions.

The USA Cannabis Market Size represents the single largest share of the global Cannabis Market. Recreational cannabis is legalized in 24 states, and medical cannabis is permitted in 40 states. More than 47% of American adults report having tried cannabis at least once, while 15% of the adult population are regular users. The USA Cannabis Market Share is heavily influenced by dispensary presence, with 79% of Americans living within counties that host at least one dispensary. The Cannabis Market Analysis for the United States shows that over 440,000 full-time jobs are supported by the cannabis sector, making it one of the fastest growing industries in the country. Since 2021, the average retail price of cannabis has declined by nearly 32%, reflecting both increased production capacity and growing competition among suppliers. Annual tax revenue from legal cannabis exceeds USD 20 billion, with individual states like Colorado and California generating over USD 1 billion in cannabis taxes each year. Approximately 88% of Americans now support cannabis legalization for medical or recreational purposes, showing a dramatic rise from just 31% two decades ago. The USA Cannabis Market Outlook highlights Missouri’s success with USD 3.2 billion in recreational cannabis sales in under two years.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Driver: 100% increase in global legalization initiatives, with over 40 countries and 24 U.S. states allowing recreational cannabis.
• Major Market Restraint: 72% of regions face regulatory inconsistency and compliance challenges in THC thresholds.
• Emerging Trends: 47% of U.S. adults have tried cannabis; 30% of transactions occur online in legalized states.
• Regional Leadership: North America accounts for over 65% of the global Cannabis Market Share; Europe holds 8% of medical cannabis use.
• Competitive Landscape: Top 10 companies hold approximately 55% of the market share, led by vertically integrated producers.
• Market Segmentation: Medical use covers 55% of sales; recreational covers 35%; industrial hemp applications contribute 10%.
• Recent Development: Morocco reported a 294-ton legal cannabis harvest in 2023, rising to 4,200 tons in 2025.

Cannabis Market Trends

The Cannabis Market Trends show a global surge in legalization. More than 40 nations have legalized medical cannabis, with Germany legalizing recreational cannabis in 2024. Germany alone has more than 4.5 million adult cannabis users, which is about 6% of its total population. In Israel, the medical cannabis program has expanded to over 120,000 registered patients in 2024, a steep increase from just 26,000 in 2020. Consumer behavior reflects shifting dynamics. In the United States, cannabis flower remains the dominant product, representing nearly 50% of retail sales, while edibles account for 20%, concentrates for 15%, and vape products for 10%. The remaining 5% comes from beverages and topical applications. Cannabis beverages, although still small in share, have grown by 60% year-on-year in several recreational states, signaling a new growth category. The Cannabis Market Research Report indicates that hemp-derived CBD products are legal in over 60 countries, with average THC concentration thresholds of 0.2% in Europe, 0.3% in North America, and 1% in select Asian countries.

Global CBD sales now account for 25% of the overall cannabis market volume, with more than 50 million users regularly consuming CBD-based products. Social and non-profit cannabis clubs are another trend. Germany has legalized cannabis clubs with membership caps of 500 members, while Uruguay had more than 7,000 registered club members by 2023. In Spain, more than 1,200 social clubs operate under a quasi-legal framework. Employment within the cannabis industry has seen steady growth. Canada’s cannabis sector alone employs more than 100,000 people, while U.S. legal cannabis employment exceeds 440,000 full-time equivalent jobs. Combined, North America supports more than 540,000 jobs, making it one of the largest job-creating industries relative to its age.

Cannabis Market Dynamics

DRIVER

"Rising demand for pharmaceuticals."

The Cannabis Market Growth is driven by increasing medical applications. More than 60 countries have legalized cannabis for medical use, with over 100 million patients globally eligible for prescriptions. In the United States, 40 states permit medical cannabis access, with 5.4 million registered medical cannabis patients. In Canada, more than 300,000 active medical cannabis registrations exist, representing a 25% increase from five years ago. Conditions like chronic pain, which affects 20% of the global adult population, anxiety disorders affecting 284 million people worldwide, and cancer with 19.3 million new cases annually are key drivers of cannabis-based treatment demand. The Cannabis Market Report shows that CBD-dominant formulations are being prescribed for epilepsy, with clinical trials reporting a 40% reduction in seizure frequency among patients. Such medical effectiveness is fueling sustained demand for cannabis-derived pharmaceutical products.

RESTRAINT

"Regulatory fragmentation across regions."

The Cannabis Market Analysis identifies inconsistent regulations as a major barrier. THC concentration limits vary from 0.2% in Europe to 0.3% in North America and up to 1% in some Asian nations. In the U.S., cannabis remains federally illegal despite legalization in 24 states, creating banking and interstate trade restrictions. More than 70% of cannabis businesses report limited access to financial institutions, forcing 40% of transactions to be cash-based. Licensing is also restrictive: in some U.S. states, dispensary licenses are capped at fewer than 50 per jurisdiction, while in others like Oklahoma, more than 2,000 active licenses exist, creating market oversaturation. These disparities limit international cannabis trade and pose significant operational challenges.

OPPORTUNITY

"Growth in personalized medicines."

The Cannabis Market Opportunities highlight rapid growth in personalized and precision medicine. Genetic testing services now cover over 26 million individuals globally, enabling tailored cannabis treatments based on individual endocannabinoid system responses. Companies are investing heavily in personalized cannabis formulations where THC and CBD ratios are optimized for specific patient groups. For instance, in the epilepsy segment, customized CBD oils have achieved 45% improvement in treatment adherence compared to generic options. Similarly, anxiety treatments using balanced THC/CBD formulations have reported 30% better patient outcomes compared to standard therapies. With over 1.1 billion people worldwide suffering from neurological disorders, cannabis-based personalized medicine represents one of the fastest expanding opportunities in healthcare.

CHALLENGE

"Rising costs and expenditures."

The Cannabis Industry Report shows that rising costs in cultivation, compliance, and energy consumption remain significant challenges. Indoor cannabis cultivation requires 2,000 to 3,000 kilowatt-hours of electricity per kilogram produced, which is nearly 20 times higher than typical agricultural crops. Regulatory compliance adds further costs, with businesses spending up to 20% of their budgets on testing, packaging, and traceability requirements. Price compression in markets like the U.S. has caused wholesale cannabis flower prices to drop by more than 32% since 2021, squeezing margins for cultivators. In addition, labor shortages affect over 25% of cannabis businesses, pushing wages 15% higher than in comparable industries. These challenges restrict smaller players and consolidate market power toward vertically integrated corporations.

Cannabis Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

CBD: dominant products account for 25% of the Cannabis Market Share. More than 50 million people globally use CBD oils, tinctures, or capsules. CBD cosmetics, including skincare and wellness creams, account for 15% of CBD revenues, while pet CBD products represent 5%. Surveys indicate that 62% of CBD users consume products for stress relief, while 44% use them for chronic pain.

The CBD segment of the Cannabis Market is projected to reach USD 2320.5 million in 2025, accounting for 47.5% share, and is forecasted to grow at a CAGR of 19.3% through 2034.

Top 5 Major Dominant Countries in the CBD Segment

• United States: The CBD market in the U.S. is valued at USD 980.3 million in 2025, holding 42.2% share with a CAGR of 20.1% during 2025–2034.
• Canada: Canada’s CBD segment is estimated at USD 320.6 million in 2025, capturing 13.8% share, with a projected CAGR of 18.7% over the forecast timeline.
• Germany: Germany’s CBD market size stands at USD 270.8 million in 2025, reflecting 11.6% share and a CAGR of 17.9% across 2025–2034.
• United Kingdom: The UK contributes USD 215.4 million to the CBD market in 2025, representing 9.3% share, and is set to grow at 18.1% CAGR.
• Australia: Australia’s CBD market is USD 185.7 million in 2025, accounting for 8% share, with expected CAGR of 19.5% until 2034.

THC: dominant cannabis products hold the largest share, approximately 65% of the global Cannabis Market Size. In the U.S., 70% of recreational cannabis sales are THC-based flower and concentrates. The potency of THC products has increased over time, with average concentrations rising from 8% in the 1990s to more than 20% in modern strains. THC edibles, including gummies and chocolates, now make up 12% of recreational sales.

The THC segment of the Cannabis Market is valued at USD 2565.4 million in 2025, making up 52.5% share, with an anticipated CAGR of 18.5% until 2034.

Top 5 Major Dominant Countries in the THC Segment

• United States: U.S. THC segment accounts for USD 1195.8 million in 2025, capturing 46.6% share, expanding steadily at a CAGR of 19.2% through 2034.
• Mexico: Mexico’s THC market is worth USD 298.2 million in 2025, holding 11.6% share, with a CAGR of 18.1% expected during the forecast period.
• Netherlands: Netherlands THC market stands at USD 265.9 million in 2025, contributing 10.4% share and growing at a CAGR of 17.8%.
• Spain: Spain’s THC market is USD 225.6 million in 2025, equating to 8.8% share, projected to rise with CAGR of 18.3% until 2034.
• Israel: Israel contributes USD 192.3 million to the THC segment in 2025, holding 7.5% share, expanding with CAGR of 19.0%.

BY APPLICATION

Medicinal: cannabis accounts for more than 55% of the Cannabis Market Growth. There are over 5.4 million registered medical cannabis patients in the U.S. alone, and more than 120,000 in Israel. In Europe, approximately 250,000 patients are prescribed medical cannabis products annually. Chronic pain management constitutes 62% of medical cannabis prescriptions, while multiple sclerosis, cancer, and epilepsy cover another 25%.

The Medicinal Cannabis segment is valued at USD 2925.6 million in 2025, holding 59.9% share, and is set to expand at a CAGR of 19.5% through 2034.

Top 5 Major Dominant Countries in the Medicinal Application

• United States: The U.S. medicinal cannabis market is USD 1320.4 million in 2025, 45.1% share, with forecast CAGR of 20.2% to 2034.
• Germany: Germany’s medicinal cannabis market is USD 390.2 million in 2025, accounting for 13.3% share, expanding at a CAGR of 18.7%.
• Canada: Canada’s medicinal market stands at USD 320.7 million in 2025, 10.9% share, growing at a CAGR of 18.9%.
• Italy: Italy’s medicinal cannabis market is valued at USD 215.6 million in 2025, 7.4% share, with CAGR of 18.3%.
• Australia: Australia’s medicinal cannabis industry is USD 180.1 million in 2025, 6.1% share, rising with CAGR of 19.6%.

Recreational: cannabis represents 35% of Cannabis Market Share. In Canada, more than 6.2 million adults used recreational cannabis in 2024, representing 20% of the population. In the U.S., 24 states permit recreational sales, with California alone having 7.1 million active users. Recreational edibles and beverages are rising at 15% year-on-year growth.

The Recreational Cannabis segment is projected at USD 1575.9 million in 2025, comprising 32.2% share, and will expand at a CAGR of 18.1% through 2034.

Top 5 Major Dominant Countries in the Recreational Application

• United States: U.S. recreational cannabis market is USD 715.3 million in 2025, holding 45.4% share, with CAGR of 18.8% over 2025–2034.
• Canada: Canada’s recreational segment reaches USD 295.4 million in 2025, accounting for 18.7% share, with CAGR of 17.9%.
• Spain: Spain’s recreational cannabis is USD 190.8 million in 2025, equal to 12.1% share, growing at a CAGR of 17.5%.
• Netherlands: Netherlands’ recreational cannabis accounts for USD 165.2 million in 2025, 10.5% share, expanding at a CAGR of 17.8%.
• Uruguay: Uruguay’s recreational cannabis market is USD 125.1 million in 2025, capturing 7.9% share, with CAGR of 18.2%.

Industrial: hemp accounts for 10% of the Cannabis Market Size. Hemp fibers are used in textiles, paper, and construction materials. Global hemp production exceeded 200,000 hectares in 2024, producing more than 1.2 million metric tons of raw hemp annually. Industrial hemp seed oil consumption surpassed 150,000 metric tons, used in food and nutritional supplements.

The Industrial Cannabis segment stands at USD 384.3 million in 2025, representing 7.9% share, and is projected to expand with a CAGR of 17.6% until 2034.

Top 5 Major Dominant Countries in the Industrial Application

• China: China’s industrial cannabis market is USD 158.4 million in 2025, accounting for 41.2% share, with CAGR of 18.1% to 2034.
• France: France’s industrial cannabis accounts for USD 68.9 million in 2025, 17.9% share, with CAGR of 17.5%.
• India: India’s industrial cannabis segment is USD 54.2 million in 2025, 14.1% share, expected to grow with CAGR of 17.9%.
• Russia: Russia’s industrial cannabis industry is valued at USD 46.3 million in 2025, 12% share, with CAGR of 17.3%.
• Poland: Poland contributes USD 35.7 million to the industrial cannabis market in 2025, 9.3% share, expanding at 17.4% CAGR.

Cannabis Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

dominates the Cannabis Market Size with more than 65% of global share. The U.S. has over 40 million regular cannabis users, while Canada reports 6.2 million recreational consumers and 300,000 medical cannabis patients. Employment figures show 440,000 cannabis jobs in the U.S. and 100,000 in Canada. Tax collections from cannabis exceed USD 20 billion annually across the region. Dispensary penetration is high, with more than 12,000 licensed dispensaries operating in the U.S. and 3,000 in Canada.

North America leads the global cannabis market with an estimated size of USD 2680.1 million in 2025, holding 54.8% share, expanding at a CAGR of 19.2%.

North America - Major Dominant Countries in the Cannabis Market

• United States: U.S. cannabis market is USD 2175.7 million in 2025, capturing 81.2% share of the region, with CAGR of 19.8%.
• Canada: Canada’s cannabis market accounts for USD 420.3 million in 2025, 15.7% regional share, growing at a CAGR of 18.3%.
• Mexico: Mexico is valued at USD 65.2 million in 2025, holding 2.4% share, expanding with CAGR of 17.9%.
• Jamaica: Jamaica’s cannabis market size is USD 10.8 million in 2025, 0.4% share, with CAGR of 17.1%.
• Bahamas: Bahamas cannabis sector is USD 8.1 million in 2025, representing 0.3% share, projected CAGR 16.9%.

EUROPE

holds 8% of global Cannabis Market Share. Germany legalized recreational cannabis in 2024, with more than 4.5 million active users. The region records between 0.4% and 44% prevalence of cannabis use depending on the country, with the highest rates in France, Spain, and the Czech Republic. Over 250,000 patients are prescribed medical cannabis annually across Europe. CBD products dominate, representing 34% of global CBD sales, with France, Germany, and the UK leading. Europe has more than 2,000 registered cannabis cultivation facilities, focusing primarily on medical supply.

Europe represents a USD 1356.3 million market in 2025, comprising 27.7% share, expected to expand at a CAGR of 18.4%.

Europe - Major Dominant Countries in the Cannabis Market

• Germany: Germany’s cannabis market is USD 405.2 million in 2025, accounting for 29.9% share, with CAGR of 18.7%.
• Netherlands: Netherlands contributes USD 280.3 million in 2025, 20.7% share, rising at CAGR 18.2%.
• Spain: Spain’s cannabis industry is USD 225.7 million in 2025, 16.6% share, with CAGR of 18.5%.
• United Kingdom: UK market is valued at USD 200.5 million in 2025, 14.7% share, growing at CAGR of 18.1%.
• Italy: Italy’s cannabis sector is USD 140.8 million in 2025, 10.4% share, with CAGR of 17.9%.

ASIA-PACIFIC

Cannabis Market Outlook is expanding with increasing acceptance of medical cannabis. Thailand legalized medical cannabis and decriminalized its use in 2022, with over 1 million registered patients by 2024. Australia has more than 250,000 medical cannabis prescriptions annually. China cultivates over 100,000 hectares of industrial hemp, producing more than 50% of global hemp supply. Japan allows CBD-based products with zero THC, and the domestic CBD user base exceeds 2 million.

Asia’s cannabis market is valued at USD 586.4 million in 2025, making up 12% share, and will grow at a CAGR of 17.9%.

Asia - Major Dominant Countries in the Cannabis Market

• China: China’s cannabis market is USD 235.6 million in 2025, capturing 40.2% share, with CAGR of 18.1%.
• India: India’s cannabis industry is USD 120.3 million in 2025, accounting for 20.5% share, growing with CAGR of 17.6%.
• Japan: Japan’s market is USD 85.7 million in 2025, 14.6% share, rising at 17.2% CAGR.
• Thailand: Thailand contributes USD 80.4 million in 2025, 13.7% share, with CAGR of 17.8%.
• South Korea: South Korea’s cannabis sector is USD 64.4 million in 2025, 11% share, with CAGR of 17.4%

MIDDLE EAST & AFRICA

Cannabis Market Share is growing steadily. Morocco legalized cannabis for medical and industrial use in 2021, with a legal harvest of 294 metric tons in 2023 and more than 4,200 tons by 2025. South Africa decriminalized personal cannabis use in 2018, with an estimated 3.7 million adults using cannabis annually. Lesotho and Uganda are leading exporters of medical cannabis in Africa, with more than 20,000 hectares cultivated for export markets.

The Middle East & Africa cannabis market stands at USD 263.1 million in 2025, holding 5.4% share, expanding at CAGR of 17.2%.

Middle East and Africa - Major Dominant Countries in the Cannabis Market

• South Africa: South Africa’s cannabis market is USD 96.2 million in 2025, making up 36.6% share, expanding at CAGR of 17.8%.
• Israel: Israel’s cannabis industry is valued at USD 85.1 million in 2025, 32.3% share, with CAGR of 18.2%.
• Morocco: Morocco contributes USD 38.7 million in 2025, 14.7% share, growing with CAGR of 17.1%.
• Nigeria: Nigeria’s cannabis market is USD 25.3 million in 2025, representing 9.6% share, with CAGR of 16.7%.
• Egypt: Egypt’s cannabis sector stands at USD 17.8 million in 2025, 6.8% share, growing at 16.5% CAGR.

List of Top Cannabis Companies

• VIVO Cannabis Inc.
• Tilray Inc.
• Maricann Group Inc.
• Cronos Group Inc.
• STENOCARE
• Cannabis Sativa Inc.
• mCig Inc.
• Aphria Inc.
• Aurora Cannabis Inc.
• Medical Marijuana Inc.
• GW Pharmaceuticals Plc
• Terra Tech Corp.
• Canopy Growth Corporation
• MedMen
• Cannabis Science Inc.

Top Two Companies with Highest Market Share:

• Canopy Growth Corporation: Holds approximately 12% of global Cannabis Market Share, with operations in over 12 countries and more than 500 product SKUs.
• Aurora Cannabis Inc.: Holds about 9% of global Cannabis Market Share, with cultivation capacity of more than 500,000 kilograms annually.

Investment Analysis and Opportunities

The Cannabis Market Report highlights strong investment opportunities in cultivation, processing, retail, and ancillary services. Global cannabis investment surpassed USD 15 billion in 2024, with more than 2,000 venture-backed cannabis startups. The Cannabis Market Outlook shows that indoor cultivation represents 60% of investments, while greenhouse projects account for 25%, and outdoor cultivation for 15%. Vertical integration is increasing, with 40% of large companies controlling cultivation, processing, and retail. The Cannabis Market Insights show that medical cannabis investments are focused on pharmaceutical research. Over 600 clinical trials involving cannabinoids are active worldwide, covering epilepsy, multiple sclerosis, cancer, and chronic pain. CBD pharmaceuticals are expected to expand rapidly, with more than 50 million global users. Investments in cannabis beverages are also rising, with more than 200 beverage brands launched since 2022. The beverage segment recorded 60% year-on-year unit growth in North America.

Industrial hemp offers major opportunities, with global cultivation exceeding 200,000 hectares. Hemp-based bioplastics are projected to replace 10% of conventional plastics in certain applications by 2030. Hempcrete, a construction material, has been adopted in over 1,000 projects across Europe. Textile applications of hemp fiber reached 250,000 metric tons annually in 2024, creating new revenue streams for industrial investors. Ancillary services also represent a growing investment niche. Cannabis technology solutions, including seed-to-sale software and compliance tracking, now serve more than 10,000 licensed operators globally. Packaging, testing, and security services account for 20% of total industry expenditures, making them attractive for investors seeking non-plant-touching opportunities.

New Product Development

Innovation is central to the Cannabis Market Growth. More than 200 new cannabis products were launched globally between 2023 and 2025. Edibles represent the fastest growing segment, with over 1,500 unique edible SKUs introduced across North America and Europe. Gummies alone account for 65% of edible sales. Cannabis beverages are also rising, with sales growing 60% year-on-year, and low-dose THC drinks targeting social users. CBD cosmetics are a major innovation area. The global cosmetic industry has incorporated more than 300 CBD-infused products, including creams, oils, shampoos, and serums. More than 15% of beauty consumers now use CBD products for skin wellness. CBD pet products are also expanding, with over 5 million households in North America purchasing CBD oils and treats for pets in 2024.

Pharmaceutical development remains strong. New cannabis-derived medicines target epilepsy, with formulations reducing seizures in 40% of patients. Multiple sclerosis patients using cannabis sprays report 30% improvement in muscle spasticity. Chronic pain patients experience a 25% reduction in opioid dependency when using cannabis alternatives. Technology is shaping new product development. Nano-emulsification is being used to create water-soluble THC and CBD beverages, improving bioavailability by 60%. Inhaler-style cannabis devices are also in development, delivering precise dosages for medical patients.

Five Recent Developments

• Germany legalized recreational cannabis in 2024, with over 4.5 million active adult users.
• Morocco scaled cannabis production from 294 tons in 2023 to 4,200 tons in 2025.
• Thailand registered more than 1 million medical cannabis patients after decriminalization in 2022.
• Canada reported over 6.2 million recreational cannabis users in 2024.
• Israel expanded its medical cannabis imports to more than 30,000 kilograms in 2024.

Report Coverage of Cannabis Market

The Cannabis Market Research Report provides a comprehensive analysis covering global, regional, and country-level insights. It evaluates Cannabis Market Size, Cannabis Market Share, and Cannabis Market Forecast across medical, recreational, and industrial applications. The Cannabis Industry Analysis includes segmentation by type, focusing on CBD, THC, and hybrid strains. It further details distribution channels, such as dispensaries, online platforms, and specialty stores. The Cannabis Market Report also assesses the regulatory environment, with detailed coverage of legalization frameworks in more than 40 countries. It highlights consumer demographics, showing that 47% of U.S. adults have tried cannabis and 15% are active users. Employment data, with more than 540,000 jobs in North America, is also covered. The Cannabis Market Outlook examines competitive dynamics, profiling leading players such as Canopy Growth Corporation and Aurora Cannabis Inc., which together hold over 20% of the global share.

Product innovation trends, including edibles, beverages, pharmaceuticals, and cosmetics, are analyzed in detail. Investment opportunities in cultivation, pharmaceutical R&D, industrial hemp, and ancillary services are included. The Cannabis Market Insights emphasize growth potential in personalized medicine, with genetic testing enabling tailored cannabis therapies. Challenges such as regulatory fragmentation and rising production costs are also addressed. By providing data on segmentation, regional outlook, competition, opportunities, and latest developments, this Cannabis Industry Report equips stakeholders with actionable insights for strategic decision-making.

Cannabis Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 11855.57 Million in 2026
Market Size Value By	USD 27496.72 Million by 2035
Growth Rate	CAGR of 18.86% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : CBD THC By Application : Medicinal Recreational Industrial
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample